Catalyst Wire Dossier Catalyst Wire Dossier

Cagrilintide

cagrilintide · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Cagrilintide, covering 2023-07-27 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide [Phase 3]

See pricing